Excess Body Weight Linked to Increased Risk for Second Primary Neoplasm

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 19, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, Sept. 19, 2024 -- Among cancer survivors, excess body weight is associated with an increased risk for a second primary malignant neoplasm, according to a study published online Sept. 17 in JAMA Network Open.

Clara Bodelon, Ph.D., from the American Cancer Society in Atlanta, and colleagues examined whether excess body weight is associated with the risk for a second primary malignant neoplasm among cancer survivors using data from the Cancer Prevention Study II Nutrition cohort. Eligible participants had received a diagnosis of first primary nonmetastatic invasive cancer between 1992 and 2015 (26,894 participants; mean age at first cancer diagnosis, 72.2 years).

At the time of first diagnosis, 42.8 and 17.2 percent of the participants had overweight and obesity, respectively. The researchers found that 13.9 percent of the participants received a diagnosis of second primary cancer during a median follow-up of 7.9 years, of which 33.2 percent were obesity-related second primary cancers. The risk for any second primary cancer was increased for those who had overweight and obesity compared with cancer survivors whose body mass index was in the normal range (adjusted hazard ratios, 1.15 and 1.34, respectively), with greater risks for obesity-related second primary cancers (adjusted hazard ratios, 1.40 and 1.78, respectively).

"Given the high prevalence of overweight and obesity among cancer survivors, these findings have important public health implications and may inform evidence-based survivorship guidelines to reduce the risk of second primary cancers among cancer survivors," the authors write.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-09-20 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords